Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, DIS, DEI

LUCID HEARING LAUNCHES ONE OF THE INDUSTRY'S MOST DISCREET IN-EAR HEARING DEVICES FOR CONSUMERS


Focusing on removing the stigma associated with hearing health, fiotm is a product engineered with the consumer in mind.

FORTWORTH, Texas, April 13, 2022 /PRNewswire/ -- As part of their continued customer-focused approach Lucid Hearing launches one of the industry's most technologically advanced hearing aids. Developed by leveraging over 20 years of hearing health experience and a focus on the main consumer concern around discreet fit, fio, is Lucid Hearing's smallest in-canal, rechargeable hearing aid.

"Fio is focused on delivering the most comfortable fit and function for the active individual who is looking to maximize every moment of their lives. Hearing health is a right of every individual and our goal at Lucid Hearing is to simply help people hear better" said Jason Kidd, CEO Lucid Hearing "and part of that responsibility is to make products that are ready for use, discreet in nature and empower the end user to customize their hearing profile."

Compatible with LucidShapetm, fio allows the user to develop custom hearing levels for all types of environments making wearing fio a way to bring the user back into the conversation.

For more information visit fiohears.com

About Lucid Hearing:
Lucid Hearing's mission is to advance hearing healthcare holistically across our family of brands that encompass hearing enhancement, enjoyment, protection, detection, and wellness. We believe every human should have access to better hearing, and we are proud to offer free online and in-store assessments at over 500 Lucid Hearing clinics nationwide.

SOURCE Lucid Hearing


These press releases may also interest you

at 16:25
Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics
Precision BioSciences, Inc. , an advanced gene editing company, today announced the anticipated return of three programs from Prevail Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company. Precision exercised its option to regain...

at 16:25
Measles is Back Thanks to Vaccination Backlash, Notes AHF
AIDS Healthcare Foundation (AHF), the world's largest HIV/AIDS organization, is calling on public health officials to provide more education and prevention services around vaccinations as a new measles outbreak spreads through 17 U.S. states. As of...

at 16:22
Baylin Technologies Announces Award of Over $655k (CAD) for NASA's Lunar Exploration Initiative
Baylin Technologies Inc. (the "Company") is pleased to announce that its Advantech Wireless subsidiary has received a new award valued at over $655,000 (CAD) for high-power SSPA systems to support NASA's Lunar Exploration and Colonization...

at 16:19
Prime Healthcare, EmVenio Research and Health Wizz Announce Strategic Partnership and Launch of EmVenio Research Center at Prime Healthcare
Community research provider EmVenio Research and Prime Healthcare, an award-winning national health system, today announce their partnership to launch the EmVenio Research Center at Prime Healthcare. The partnership allows EmVenio to conduct research...

at 16:15
Ontrak Announces 2023 Fourth Quarter and Year End Financial Results
Ontrak, Inc. ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today reported its financial results for the fourth quarter and year ended December 31, 2023. Management Commentary "In addition to new...

at 16:15
EA to Release Fourth Quarter and Fiscal Year 2024 Results on May 7, 2024
Electronic Arts Inc. will release its financial results for the fiscal quarter and year ended March 31, 2024 after the close of market on Tuesday, May 7, 2024. In conjunction with this release, EA will host a conference call to review its financial...

More news about Science and technology...


News published on and distributed by: